Gene · 4841
Papers2,010
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,010
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers. | Front Oncol | 2022 | 36263200 | PubTator, text mining | PubMed |
| Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. | J Immunother Cancer | 2022 | 36252997 | PubTator, text mining | PubMed |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. | Adv Drug Deliv Rev | 2022 | 36252617 | PubTator, text mining | PubMed |
| Deep Learning Approaches for Detection of Breast Adenocarcinoma Causing Carcinogenic Mutations. | Int J Mol Sci | 2022 | 36232840 | PubTator, text mining | PubMed |
| Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors. | Cancers (Basel) | 2022 | 36230794 | PubTator, text mining | PubMed |
| Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO. | Front Pharmacol | 2022 | 36225557 | PubTator, text mining | PubMed |
| Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip® assay in TK6 cells. | Front Toxicol | 2022 | 36211197 | PubTator, text mining | PubMed |
| Paraspeckle subnuclear bodies depend on dynamic heterodimerisation of DBHS RNA-binding proteins via their structured domains. | J Biol Chem | 2022 | 36209820 | PubTator, text mining | PubMed |
| A Novel Gene Controls a New Structure: PiggyBac Transposable Element-Derived 1, Unique to Mammals, Controls Mammal-Specific Neuronal Paraspeckles. | Mol Biol Evol | 2022 | 36205081 | PubTator, text mining | PubMed |
| Keeping up with the condensates: The retention, gain, and loss of nuclear membrane-less organelles. | Front Mol Biosci | 2022 | 36203874 | PubTator, text mining | PubMed |
| Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. | Mol Cancer | 2022 | 36199071 | PubTator, text mining | PubMed |
| AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells. | PLoS One | 2022 | 36194562 | PubTator, text mining | PubMed |
| Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. | Front Endocrinol (Lausanne) | 2022 | 36187110 | PubTator, text mining | PubMed |
| Enabling factor for cancer hallmark acquisition: Small nucleolar RNA host gene 17. | Front Oncol | 2022 | 36185210 | PubTator, text mining | PubMed |
| SFPQ promotes RAS-mutant cancer cell growth by modulating 5'-UTR mediated translational control of CK1α. | NAR Cancer | 2022 | 36177382 | PubTator, text mining | PubMed |
| Familial ALS-associated SFPQ variants promote the formation of SFPQ cytoplasmic aggregates in primary neurons. | Open Biol | 2022 | 36168806 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation. | Int J Mol Sci | 2022 | 36142814 | PubTator, text mining | PubMed |
| The Long and the Short of It: NEAT1 and Cancer Cell Metabolism. | Cancers (Basel) | 2022 | 36139550 | PubTator, text mining | PubMed |
| Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy. | Cells | 2022 | 36139386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/papers?page=19